![Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors](/docs/US/2018-03-20/US09918990B2/abs.jpg.600x600.jpg)
- 专利标题： Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
-
申请号： US15186697申请日： 2016-06-20
-
公开(公告)号： US09918990B2公开(公告)日： 2018-03-20
- 发明人: Eddy W. Yue , Andrew P. Combs , Brent Douty
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 代理机构： Fish & Richardson P.C.
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/538 ; A61K31/437 ; A61K31/4545 ; A61K31/496 ; A61K31/498 ; A61K31/519 ; A61K31/5377
![Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors](/abs-image/US/2018/03/20/US09918990B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to compounds represented by the general Formula I which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
公开/授权文献
- US20170014418A1 BICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS 公开/授权日：2017-01-19
信息查询
